Pirfenidone is an approved pharmacological agent for the treatment of Idiopathic Pulmonary Fibrosis (IPF). This video attempts to explain the effects, mechanism of action and clinical trials of pirfenidone use.
This video was made in the McMaster Demystifying Medicine Program by HTS 4DM3 students Maria Shaikh, Shiza Sheikh, Gurteg Singh, Jelena Poleksic and Kaushik Sripada. Please let us know if you have comments and suggestions.
Copyright McMaster University 2016
#DemystifyingMedicine, #IPF
![10 Cool James Hetfield Leads | [+Tab]](https://i.ytimg.com/vi/uKil0I93N9Y/mqdefault.jpg)
